Navigation Links
Genetics May Help Fine-Tune Warfarin Dosage
Date:2/18/2009

Formula that includes DNA data proves faster, more accurate in early tests

WEDNESDAY, Feb. 18 (HealthDay News) -- A DNA test could make prescribing the widely used anticoagulant warfarin safer by predicting the lowest effective dose, a new study finds.

The U.S. Food and Drug Administration estimates that 2 million Americans take warfarin to prevent potentially dangerous blood clots that can cause strokes. Reasons range from implantation of an artificial heart valve to the abnormal heartbeat called atrial fibrillation. But establishing and maintaining the ideal dose is done by trial and error, with weekly and monthly monitoring.

"In a very large group of patients, we showed that the use of genetics helps predict the right dose, and this may take the dangerous guesswork out of prescribing warfarin," said Dr. Russ Altman, a professor of bioengineering, genetics and medicine at Stanford University School of Medicine and a co-author of the study. This "may be one of the first widely-used examples of pharmacogenetics -- the use of genetic information to make better prescribing decisions," he said.

Because an effective dose of warfarin can vary as much as 10-fold from one person to the next, doctors start most people on a low dose and increase it until blood tests indicate the dose is correct. That process can take months.

For the study, which is published in the Feb. 19 issue of the New England Journal of Medicine, researchers collected demographic and genetic data on people at risk for stroke, heart disease and other problems related to blood clotting. The ideal doses of warfarin for these individuals had already been established by trial and error.

In addition, they looked at variants of two genes: CYP2C9, which affects how the liver activates and excretes warfarin, and VKORC1, which activates vitamin K, essential for blood clotting.

They used the data to create an algorithm that
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Genetics Hold Promise, Challenges for Cancer Care
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Salugen to Present Research on Generational Associations of Reward Deficiency Syndrome at XVth World Congress on Psychiatric Genetics
4. Obesity genetics
5. The genetics of MLL leukemogenesis
6. Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting
7. Clarient Names Michele Hibbard, Ph.D. Director of Genetics
8. Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference
9. Interleukin Genetics to Host Third Quarter 2007 Financial Results Conference Call November 7
10. Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday, November 14, 2007
11. Response Genetics Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetics May Help Fine-Tune Warfarin Dosage
(Date:3/30/2015)... (PRWEB) March 30, 2015 Wright & ... liability lawsuits, notes that the number of Syngenta ... litigation underway in U.S. District Court, District of Kansas, ... December 2014. "According to an update released by the ... 16th, at least 493 Syngenta lawsuits are now consolidated ...
(Date:3/30/2015)... AL (PRWEB) March 30, 2015 Southern ... malpractice and defective medical devices, has filed a ... family whose baby died following his premature birth in ... County Circuit Court, alleges that the Mirena IUD failed ... which also made the device difficult to remove. The ...
(Date:3/30/2015)... are pleased to announce three volunteer pilot recipients of ... Angeles,” said Mark Wolper, Chair of Endeavor Awards. “There ... call for nominations. , The awards recipients are ... LightHawk and Stephen Purello of Angel Flight Southeast. ... a $15,000 contribution from the Endeavor Awards Ceremony and ...
(Date:3/30/2015)... Atlanta, Georgia (PRWEB) March 30, 2015 ... for healthcare professionals worldwide, today announced it is expanding ... innovative solutions for this area of the world comes ... are rallying around consumer demand for better healthcare. A ... driving healthcare system improvements and advances in medicine in ...
(Date:3/30/2015)... Vancouver personal injury lawyer firm, Jiwa Law Corporation, ... up by the firm are settled before they go ... the interests of their clients without them having to ... across as an achievement for the personal injury lawyers, ... their client, without compromising their rights. , By ...
Breaking Medicine News(10 mins):Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:2015 Endeavor Awards Recipients Announced 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2
... Partner in Madrid, Spain has developed a creative solution of ... encourage discussions between medical professionals. , ... ... Scala , the leading provider of end-to-end solutions for the ...
... 35 and older treat the symptoms associated with ... hormone replacement therapy program. The staff at ReNEW ... safe, effective treatment. The company is currently working ... optimization. By improving their visibility on major search ...
... has launched an informational site, www.citepatents.com , to help bloggers, ... free patent search box for adding to websites with a single ... ... December 17, 2008 -- Due to an impartial, peer-reviewed nature, ...
... levels unlikely to be achieved in real life , , ... identified anti-cancer chemicals in extra-virgin olive oil that may ... oil-rich Mediterranean diet and a reduced risk of breast ... pressing olives without the use of heat or chemical ...
... N.C., Dec. 17 Creative Visions, Inc., a ... Raleigh, announced,today that the company was acquired by ... Creative Visions is ... profile productions held at the Palace of Versailles, ...
... Retailers; PureVia(TM) Makes its U.S. Debut in Zero-Calorie SoBe Lifewater(R), ... Tropicana in First Quarter 2009 , , ... Earth Sweetener Company LLC and PepsiCo announced today that the ... letter with respect to Rebaudioside A (Reb A), the stevia ...
Cached Medicine News:Health News:Medical Congresses Employ Interactive Digital Posters to Deliver Dynamic Content to Medical Professionals 2Health News:Medical Congresses Employ Interactive Digital Posters to Deliver Dynamic Content to Medical Professionals 3Health News:Medical Congresses Employ Interactive Digital Posters to Deliver Dynamic Content to Medical Professionals 4Health News:Medical Congresses Employ Interactive Digital Posters to Deliver Dynamic Content to Medical Professionals 5Health News:Male Menopause Treatment Provider, ReNEW MAN, Increases Online Presence 2Health News:Male Menopause Treatment Provider, ReNEW MAN, Increases Online Presence 3Health News:Male Menopause Treatment Provider, ReNEW MAN, Increases Online Presence 4Health News: FreePatentsOnline Launches the CitePatents Program : Making it Easy for Bloggers and Journalists to Reference Patents, and Add Patent Search to Websites 2Health News:Phenols in Quality Olive Oil Suppress Breast Cancer Gene 2Health News:Creative Visions Acquired by Interactive Holdings 2Health News:Creative Visions Acquired by Interactive Holdings 3Health News:Photos: U.S. Food and Drug Administration Issues No Objection Letter to GRAS Status of Rebaudioside A 2Health News:Photos: U.S. Food and Drug Administration Issues No Objection Letter to GRAS Status of Rebaudioside A 3Health News:Photos: U.S. Food and Drug Administration Issues No Objection Letter to GRAS Status of Rebaudioside A 4Health News:Photos: U.S. Food and Drug Administration Issues No Objection Letter to GRAS Status of Rebaudioside A 5Health News:Photos: U.S. Food and Drug Administration Issues No Objection Letter to GRAS Status of Rebaudioside A 6
(Date:3/30/2015)... March 30, 2015   MultiVir Inc. ("MultiVir"), ... novel product candidates for the treatment of multiple oncological ... registration statement on Form S-1 with the U.S. Securities ... public offering of shares of its common stock. The ... range for the proposed offering have not yet been ...
(Date:3/30/2015)... HARBIN, China, March 30, 2015 Nutrastar International ... producer and supplier of premium branded consumer products, including ... organic and specialty foods, today announced its results for ... Financial Highlights for the Full Year Ended December ... was $43.33 million, as compared to $43.35 million in ...
(Date:3/30/2015)... , March 30, 2015  BioPharmX Corporation (OTCQB: ... development of novel drug delivery products to address ... today announced the appointment of Stephen Morlock ... veteran, to its board of directors.  Mr. Morlock,s ... to expand its national roll-out of Violet iodine, ...
Breaking Medicine Technology:MultiVir Files Registration Statement for Proposed Initial Public Offering 2Nutrastar International, Inc. Announces Full Year 2014 Results 2Nutrastar International, Inc. Announces Full Year 2014 Results 3Nutrastar International, Inc. Announces Full Year 2014 Results 4Nutrastar International, Inc. Announces Full Year 2014 Results 5Nutrastar International, Inc. Announces Full Year 2014 Results 6Nutrastar International, Inc. Announces Full Year 2014 Results 7Nutrastar International, Inc. Announces Full Year 2014 Results 8Nutrastar International, Inc. Announces Full Year 2014 Results 9BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3
... Resources, one of the world,s leading research and ... that, owing to its superb efficacy, acceptable safety ... Ironwood/Forest/Almirall/Astellas,s linaclotide will emerge as the market leader ... In 2019, linaclotide will garner blockbuster sales of ...
... /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: ... for serious central nervous system diseases, announced today that ... zinc-based therapy for the prevention of infections in the ... candidate portfolio that already includes its proprietary zinc-based tablets ...
Cached Medicine Technology:For Treatment of Irritable Bowel Syndrome, Linaclotide Will Emerge as the Market Leader and Will Achieve Blockbuster Status in 2019 2Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly 2Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly 3Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly 4Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly 5
... 513 handheld pulse oximeters incorporate "digital ... able to process pulsatile signals at ... 100 times per second. This processing ... performance during motion or low perfusion, ...
CO 2 SMO-Capnograph/Pulse Oximeter...
... The Models 512 and 513 ... processing. This advanced technology is able ... higher resolutions and speeds of 100 ... results in improved pulse oximeter performance ...
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
Medicine Products: